GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the C89A gmp synthetase inactive mutant from plasmodium falciparum in complex with glutamine

Analyse Crystal structure of the C89A gmp synthetase inactive mutant from plasmodium… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WIO
Type
protein
Length
525 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gmp synthetase
EC
6.3.5.2
UniProt
Q8IJR9
Ligands
GLN
Pockets
6 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGmp synthetase (EC 6.3.5.2)protein52534% helix, 24% strandQ8IJR9

Ligands and binding sites

  • GLN · Glutamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111530.810.82112empty
22560.580.7829empty
32600.570.7833empty
4750.400.7918GLN
5640.330.7618empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4WIO · Crystal structure of the C89A GMP synthetase inactive mutant from Plasmodium falciparum… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.